1King NJ, Thomas SR (2007) Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 39:2167-1272.

2Takikawa O (2005)Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 338:12-19.

3Thomas SR, Stocker R (1999) Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4:199-220.

4Lestage J, Verrier D, Palin K, Dantzer R (2002) The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen.Brain Behav Immun 16:596-601.

5Dale WE, Dang Y, Brown OR (2000)Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices. Free Radic Biol Med 29: 191-198.

6Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, et al. (2005) Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 192: 537-544.

7Schwarcz R (2004) The Kynurenine Pathway of Tryptophan Degradation as a Drug Target. Current Opinion in Pharmacology 4: 12-17.

8Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459-468.

9Obojes K, Andres O, Kim KS, Däubener W, Schneider-Schaulies J (2005) Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol 79: 7768-7776.

10Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D (2006) Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364: 82-90.

11Littlejohn TK, Takikawa O, Skylas D, Jamie JF, Walker MJ, et al.(2000) Expression and purification of recombinant human indoleamine 2, 3-dioxygenase. Protein Expr Purif 19: 22-29.

12Moroni F, Russi P, Carlá V, Lombardi G (1988) Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neurosci Lett 94: 145-150.

13Oxenkrug GF (2010) Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci 1199: 1-14.

14Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, et al. (2014) Obesity-related dysregulation of the Tryptophan-Kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity (Silver Spring) 22: 195-201.

15Zhu L, Maruvada R, Sapirstein A, Malik KU, Peters-Golden M (2010) Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier. Infect Immun 78: 4302-4310.

16Maruvada R, Zhu L, Pearce D, Sapirstein A, Kim KS (2011) Host cytosolic phospholipase A2a contributes to group B Streptococcus penetration of the blood-brain barrier. Infect Immun 79: 4088-4093.